...
首页> 外文期刊>Sexually transmitted diseases >A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection
【24h】

A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection

机译:乙酶试验和靶向环丙沙星治疗的成本分析与Neisseria淋病感染的推荐2药物治疗

获取原文
获取原文并翻译 | 示例

摘要

Background Novel approaches to combating drug-resistant Neisseria gonorrhoeae infections are urgently needed. Targeted therapy with ciprofloxacin has been made possible by a rapid assay for genotyping the gyrase A (gyrA) gene; a nonmutated gene reliably predicts susceptibility to ciprofloxacin.
机译:迫切需要迫切需要对抗耐药性耐药性的耐药性淋病淋病性感染的新方法。 通过快速测定来进行聚氯氟沙星的靶向治疗,用于基因分型乙酶A(Gyra)基因; 非融合基因可靠地预测对环丙沙星的易感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号